496 related articles for article (PubMed ID: 31105570)
1. Current Development of siRNA Bioconjugates: From Research to the Clinic.
Chernikov IV; Vlassov VV; Chernolovskaya EL
Front Pharmacol; 2019; 10():444. PubMed ID: 31105570
[TBL] [Abstract][Full Text] [Related]
2. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
4. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.
Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC
J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808
[TBL] [Abstract][Full Text] [Related]
5. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
6. Cellular delivery in vivo of siRNA-based therapeutics.
Aigner A
Curr Pharm Des; 2008; 14(34):3603-19. PubMed ID: 19075737
[TBL] [Abstract][Full Text] [Related]
7. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
8. Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma.
Höbel S; Appeldoorn CC; Gaillard PJ; Aigner A
Pharmaceuticals (Basel); 2011 Dec; 4(12):1591-1606. PubMed ID: 27721338
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
10. Chemical and structural modifications of RNAi therapeutics.
Ku SH; Jo SD; Lee YK; Kim K; Kim SH
Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
[TBL] [Abstract][Full Text] [Related]
11. Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.
Tai W
Molecules; 2019 Jun; 24(12):. PubMed ID: 31200490
[TBL] [Abstract][Full Text] [Related]
12. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
De Paula D; Bentley MV; Mahato RI
RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
[TBL] [Abstract][Full Text] [Related]
14. Advances in targeted delivery of small interfering RNA using simple bioconjugates.
Nielsen C; Kjems J; Sørensen KR; Engelholm LH; Behrendt N
Expert Opin Drug Deliv; 2014 May; 11(5):791-822. PubMed ID: 24669756
[TBL] [Abstract][Full Text] [Related]
15. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
16. Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy.
Gupta K; Puri A; Shapiro BA
DNA RNA Nanotechnol; 2017 May; 4(1):1-20. PubMed ID: 34322587
[TBL] [Abstract][Full Text] [Related]
17. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in development of siRNA delivery vehicles for cancer therapy.
Kim HJ; Kim A; Miyata K; Kataoka K
Adv Drug Deliv Rev; 2016 Sep; 104():61-77. PubMed ID: 27352638
[TBL] [Abstract][Full Text] [Related]
19. RNA interference: the molecular immune system.
Bagasra O; Prilliman KR
J Mol Histol; 2004 Aug; 35(6):545-53. PubMed ID: 15614608
[TBL] [Abstract][Full Text] [Related]
20. Structural Modifications of siRNA Improve Its Performance In Vivo.
Chernikov IV; Ponomareva UA; Chernolovskaya EL
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]